KemPharm Competitors and Similar CompaniesClear all
KemPharm's competitors and similar companies include F-star Biotechnology and AKESOgen.
 KemPharm KemPharm is a biopharmaceutical company focused on the discovery and development of new, safer therapies in the areas of pain, ADHD, and other CNS diseases. |  F-star Biotechnology F-star is developing a pipeline of novel bispecific antibodies with a therapeutic focus in immuno-oncology and oncology. |  AKESOgen AKESOgen is a biomarker, genomics and pharmacogenomics contract research organization that services the academic, pharmaceutical, biotechnology and agricultural | |
Founding Date | Founding Date 2006 | Founding Date 2006 | Founding Date 2010 |
Type | Type Public | Type Private | Type Subsidiary |
Tags | |||
Locations | Locations Kissimmee, US HQ Blacksburg, US Coralville, US Coralville, US | Locations Cambridge, GB HQ Wien, AT Cambridge, US | Locations Norcross, US HQ |
Employees | Employees 333% increase | Employees 39 | Employees 6 |
Financial | |||
Revenue (est.) | Revenue (est.) $106.5m (FY, 2025) | Revenue (est.) £18.7m (FY, 2018) | Revenue (est.) N/A |
Net income | Net income $83.2m (FY, 2025) | Net income (£2.6m) (FY, 2018) | Net income N/A |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 57.3m | Total funding raised $ 1.5m |
For sources of this data, please see the company profile
View Company Profiles
F-star Biotechnology
HQ
Cambridge, GB
Employees
39
F-star is developing a pipeline of novel bispecific antibodies with a therapeutic focus in immuno-oncology and oncology.
View companyAKESOgen
HQ
Norcross, US
AKESOgen is a biomarker, genomics and pharmacogenomics contract research organization that services the academic, pharmaceutical, biotechnology and agricultural
View company